IRIS
LOMBARDO, ANGELO LEONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 439
AS - Asia 416
EU - Europa 393
SA - Sud America 9
AF - Africa 2
Totale 1.259
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 430
SE - Svezia 180
CN - Cina 169
HK - Hong Kong 136
SG - Singapore 92
IT - Italia 72
RU - Federazione Russa 48
DE - Germania 31
GB - Regno Unito 13
AT - Austria 10
BR - Brasile 8
CA - Canada 8
FI - Finlandia 7
IE - Irlanda 7
IR - Iran 6
PT - Portogallo 6
JP - Giappone 5
ES - Italia 4
CH - Svizzera 3
FR - Francia 3
IN - India 3
BG - Bulgaria 2
LT - Lituania 2
MA - Marocco 2
MK - Macedonia 2
NL - Olanda 2
AM - Armenia 1
AR - Argentina 1
BE - Belgio 1
IQ - Iraq 1
KG - Kirghizistan 1
MX - Messico 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 1.259
Salva come PNG Salva come JPEG
Città #
Hong Kong 133
Ashburn 112
Shanghai 88
Singapore 68
New York 52
Lawrence 46
Princeton 46
Milan 40
Boardman 21
Washington 17
Moscow 13
Beijing 10
Guangzhou 9
San Francisco 9
Dublin 7
Helsinki 7
Jiaxing 7
Los Angeles 6
Shenzhen 6
Nuremberg 5
Barcelona 4
Dallas 4
Monza 4
Reston 4
Vienna 4
Aveiro 3
Berlin 3
Biggleswade 3
Noisy-le-Sec 3
Ottawa 3
Tokyo 3
Xi'an 3
Zhengzhou 3
Bologna 2
Boston 2
Campo 2
Florence 2
Frankfurt am Main 2
Manassas 2
Paullo 2
Pune 2
Rome 2
San Jose 2
Segrate 2
Sofia 2
Toronto 2
Zurich 2
Amsterdam 1
Baghdad 1
Bishkek 1
Bitonto 1
Blumenau 1
Brussels 1
Dongguan 1
Essen 1
Fontana 1
Foshan 1
Francisco Beltrão 1
Fremont 1
Genova 1
Guaramirim 1
Guiyang 1
Görwihl 1
Hangzhou 1
Hanover 1
Imperatriz 1
Jianning 1
Kassel 1
Kunshan 1
La Plata 1
Lambton 1
Lausanne 1
Leicester 1
Munich 1
Nanyang 1
Newark 1
Orem 1
Pelotas 1
Penarth 1
Putian 1
Quanzhou 1
Rabat 1
Rio Verde 1
Riyadh 1
Salvador 1
Seattle 1
Sesto San Giovanni 1
Springfield 1
Stockholm 1
Suzhou 1
Tianjin 1
Tlalpan 1
Varzelândia 1
Verdellino 1
Wuhu 1
Yerevan 1
Totale 823
Salva come PNG Salva come JPEG
Nome #
Genome editing: a tool for research and therapy: Targeted genome editing hits the clinic 55
Erratum: IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism (Molecular Therapy (2017) 25(10) (2254–2269), (S1525001617303143), (10.1016/j.ymthe.2017.06.029)) 40
Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering 39
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 38
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing 36
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 34
A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice 31
Site-specific integration and tailoring of cassette design for sustainable gene transfer 30
An unbiased genome-wide analysis of zinc-finger nuclease specificity 29
Gene Modification and Three-Dimensional Scaffolds as Novel Tools to Allow the Use of Postnatal Thymic Epithelial Cells for Thymus Regeneration Approaches 29
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency 29
Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors 28
CRISPR/CAS9-BASED GENOME EDITING TO MODEL THE ANTI-LEUKEMIA IMMUNE RESPONSE AND IDENTIFY ITS MOLECULAR PLAYERS 27
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease 27
Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector 26
Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice 26
Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis 26
Targeted genome editing in human repopulating haematopoietic stem cells 25
TRPML1 links lysosomal calcium to autophagosome biogenesis through the activation of the CaMKKβ/VPS34 pathway 25
From TCR Gene Transfer to TCR Gene Editing of Central Memory T Lymphocytes for Immunotherapy of Leukemia 24
Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery 24
IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism 24
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 24
Limited transgene immune response and long-term expression of human alpha-L-iduronidase in young adult mice with mucopolysaccharidosis type I by liver-directed gene therapy 24
Genome editing for scalable production of alloantigen-free lentiviral vectors for in vivo gene therapy 24
T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency 24
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 23
TCR gene editing results in effective immunotherapy of leukaemia without the development of GvHD 23
iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF 22
Trattamento chirurgico della fibrillazione atriale associata a valvulopatia mitralica. “Maze Procedure” e chirurgia della mitrale. 22
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 22
Targeted gene addition in human epithelial stem cells by zinc-finger nuclease-mediated homologous recombination. 22
Epigenome-editing strategies to enhance oligodendroglial differentiation from human induced pluripotent stem cells 21
In vitro gene therapy of mucopolysaccharidosis type I by lentiviral vectors 21
Targeting Integration to Selected Genomic Loci and In Situ Tailoring of Cassette Design Allows Robust Transgene Expression without Perturbing Endogenous Transcription 21
Genomic instability in induced stem cells 21
Loss of transcriptional control over endogenous retroelements during reprogramming to pluripotency 20
Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice 20
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 20
Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy 20
Targeted gene therapy and cell reprogramming in Fanconi anemia 18
Deletion of a pseudogene within a fragile site triggers the oncogenic expression of the mitotic CCSER1 gene 18
Altered Cl− homeostasis hinders forebrain GABAergic interneuron migration in a mouse model of intellectual disability 18
DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes 17
Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis 17
T Cell Receptor Gene Transfer into Naive and Central Memory Lymphocytes by Lentiviral Vectors for a Safe and Effective Adoptive Immune Therapy of Leukemia 17
Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1 17
Therapeutic gene editing in CD34+ hematopoietic progenitors from Fanconi anemia patients. 16
Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I-/- iPSCs for β cell replacement 15
The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity 15
Targeted gene correction in osteopetrotic-induced pluripotent stem cells for the generation of functional osteoclasts 15
Use of critical care resources during the first 2 weeks (February 24–March 8, 2020) of the Covid-19 outbreak in Italy 15
Durable and efficient gene silencing in vivo by hit-and-run epigenome editing 14
Lipo-Xenopeptide Polyplexes for CRISPR/Cas9 based Gene editing at ultra-low dose 13
Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC for cell therapy of type 1 diabetes 13
SELECTION BY MEANS OF ARTIFICIAL TRANSACTIVATORS 13
NY-ESO-1 Single Edited T Cells to Treat Multiple Myeloma without Inducing GvHD 13
Permanent Epigenetic Gene Silencing 12
Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC-derived β cells for cell therapy of type 1 diabetes 11
Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A 11
GENE SILENCING 10
Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells 8
Methods and compositions for targeted integration 8
COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSION 7
VECTOR PRODUCTION 6
Totale 1.403
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.699
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 1 0 0
2020/202111 0 0 0 0 0 8 3 0 0 0 0 0
2021/202232 0 0 0 19 2 0 5 0 3 0 0 3
2022/2023288 99 74 24 3 2 41 8 23 6 2 6 0
2023/2024347 2 15 38 59 41 99 4 21 2 11 15 40
2024/2025637 91 16 29 79 74 106 194 48 0 0 0 0
Totale 1.403